An observational study in Lymphedema, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-01-07.
Sponsored by Chang Gung Memorial Hospital · Observational
Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.
560 studies on the registry are indexed under Lymphedema; 135 are open to participants now.
This study's enrollment of 131 is above the median of 106 across 144 observational studies indexed under Lymphedema.
Browse Lymphedema studies →Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.
Counted across the registry records on this site, refreshed daily.
From November 2014 to January 2019, a total of 131 lower limb lymphedema patients were enrolled.
Exclusion Criteria:
This retrospective cohort study enrolled 131 lower limb lymphedema patients including 10 patients who have received VLNT as their primary lymphedema surgery showing minimal post-VLNT improvement (Group I) and 121 patients without previous lymphatic surgery (Group II).
Other: Vascularized lymph node flap transfer · Other: Patients without prior lymphedema surgery
Patients who have received VLNT as their primary treatment but with minimal improvement
Patients without prior lymphedema surgery
Magnetic resonance volumetry
Magnetic resonance volumetry was used for measuring preoperative and postoperative volume changes at least 6-month after LVA.
Time frame: 6 months after LVA
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital